S, D., MP, D., J, S., G, L. R., R, S., S, P., . . . A, M. (2023). Rimonabant-Based Compounds Bearing Hydrophobic Amino Acid Derivatives as Cannabinoid Receptor Subtype 1 Ligands. ACS medicinal chemistry letters, 14(4), 479. https://doi.org/10.1021/acsmedchemlett.3c00024
Chicago Style (17th ed.) CitationS, Dvorácskó, Dimmito MP, Sebastiani J, La Regina G, Silvestri R, Pieretti S, Stefanucci A, Tömböly C, and Mollica A. "Rimonabant-Based Compounds Bearing Hydrophobic Amino Acid Derivatives as Cannabinoid Receptor Subtype 1 Ligands." ACS Medicinal Chemistry Letters 14, no. 4 (2023): 479. https://doi.org/10.1021/acsmedchemlett.3c00024.
MLA (9th ed.) CitationS, Dvorácskó, et al. "Rimonabant-Based Compounds Bearing Hydrophobic Amino Acid Derivatives as Cannabinoid Receptor Subtype 1 Ligands." ACS Medicinal Chemistry Letters, vol. 14, no. 4, 2023, p. 479, https://doi.org/10.1021/acsmedchemlett.3c00024.